Nivolumab Immunotherapy in Malignant Mesothelioma: A Case Report Highlighting a New Opportunity for Exceptional Outcomes

Patient: Male, 68 Final Diagnosis: Mesothelioma Symptoms: Dyspnea Medication: — Clinical Procedure: — Specialty: Pulmonology OBJECTIVE: Rare disease BACKGROUND: Malignant pleural mesothelioma (MPM) is a highly lethal cancer with a median survival of ∼12 months even with aggressive intervention. Fron...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Riley G., Karthik, Felix, Dugar, Anushree, Kanagarajan, Karthik, Desai, Kalpan, Bhandari, Manish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061454/
https://www.ncbi.nlm.nih.gov/pubmed/29970876
http://dx.doi.org/10.12659/AJCR.909584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061454/
https://www.ncbi.nlm.nih.gov/pubmed/29970876
http://dx.doi.org/10.12659/AJCR.909584

Ejemplares similares